{"id":39793,"date":"2023-10-02T20:15:11","date_gmt":"2023-10-02T20:15:11","guid":{"rendered":"https:\/\/solvecfs.org\/?p=39793"},"modified":"2024-02-05T20:15:48","modified_gmt":"2024-02-05T20:15:48","slug":"solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies","status":"publish","type":"post","link":"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/","title":{"rendered":"Solve Shares Guidelines on Interactions with Biopharmaceutical Companies"},"content":{"rendered":"<p>The interactions between patient advocacy organizations and biopharmaceutical companies are critical, although often complex, and collaborations between these two stakeholders have increased in recent years as patient advocacy organizations have evolved and become increasingly engaged.<\/p>\n<p>Given the complexity of drug development, many patient advocacy organizations desire clarity and guidance on effective approaches to engaging with the biopharmaceutical industry to realize their vision of meaningful therapeutics. Our team created the resource below to outline that all interactions between Solve M.E., industry, and the disease community should be transparent; should enable trust, accountability, and shared learning; and ultimately should work most efficiently and effectively toward advancing meaningful health outcomes for patients.<\/p>\n<p>Read Solve&#8217;s Guidelines on Interactions with Biopharmaceutical Companies <a href=\"https:\/\/solvecfs.org\/wp-content\/uploads\/2023\/10\/Guidelines-for-Interactions-Between-Solve-M.E.-and-Biopharmaceutical-Companies-V2-May-2023.pdf\" target=\"_blank\" rel=\"noopener\">here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The interactions between patient advocacy organizations and biopharmaceutical companies are critical, although often complex, and collaborations between these two stakeholders have increased in recent years as patient advocacy organizations have [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":37402,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"sfsi_plus_gutenberg_text_before_share":"","sfsi_plus_gutenberg_show_text_before_share":"","sfsi_plus_gutenberg_icon_type":"","sfsi_plus_gutenberg_icon_alignemt":"","sfsi_plus_gutenburg_max_per_row":"","footnotes":""},"categories":[492,34,37],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Solve Shares Guidelines on Interactions with Biopharmaceutical Companies - Solve ME\/CFS Initiative<\/title>\n<meta name=\"description\" content=\"Solve created a set of Guidelines on Interactions with Biopharmaceutical Companies to emphasize that all interactions between Solve M.E., industry, and the disease community should be transparent; should enable trust, accountability, and shared learning; and ultimately should work most efficiently and effectively toward advancing meaningful health outcomes for patients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Solve Shares Guidelines on Interactions with Biopharmaceutical Companies - Solve ME\/CFS Initiative\" \/>\n<meta property=\"og:description\" content=\"Solve created a set of Guidelines on Interactions with Biopharmaceutical Companies to emphasize that all interactions between Solve M.E., industry, and the disease community should be transparent; should enable trust, accountability, and shared learning; and ultimately should work most efficiently and effectively toward advancing meaningful health outcomes for patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/\" \/>\n<meta property=\"og:site_name\" content=\"Solve ME\/CFS Initiative\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-02T20:15:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-05T20:15:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/solvecfs.org\/wp-content\/uploads\/2022\/12\/Untitled-design-3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Karman Kregole\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Karman Kregole\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/\"},\"author\":{\"name\":\"Karman Kregole\",\"@id\":\"https:\/\/solvecfs.org\/#\/schema\/person\/c88bbebf36b00385b7b7cbc13be5c852\"},\"headline\":\"Solve Shares Guidelines on Interactions with Biopharmaceutical Companies\",\"datePublished\":\"2023-10-02T20:15:11+00:00\",\"dateModified\":\"2024-02-05T20:15:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/\"},\"wordCount\":127,\"publisher\":{\"@id\":\"https:\/\/solvecfs.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/solvecfs.org\/wp-content\/uploads\/2022\/12\/Untitled-design-3.png\",\"articleSection\":[\"Advocacy\",\"Partners\",\"Research\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/\",\"url\":\"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/\",\"name\":\"Solve Shares Guidelines on Interactions with Biopharmaceutical Companies - Solve ME\/CFS Initiative\",\"isPartOf\":{\"@id\":\"https:\/\/solvecfs.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/solvecfs.org\/wp-content\/uploads\/2022\/12\/Untitled-design-3.png\",\"datePublished\":\"2023-10-02T20:15:11+00:00\",\"dateModified\":\"2024-02-05T20:15:48+00:00\",\"description\":\"Solve created a set of Guidelines on Interactions with Biopharmaceutical Companies to emphasize that all interactions between Solve M.E., industry, and the disease community should be transparent; should enable trust, accountability, and shared learning; and ultimately should work most efficiently and effectively toward advancing meaningful health outcomes for patients.\",\"breadcrumb\":{\"@id\":\"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/#primaryimage\",\"url\":\"https:\/\/solvecfs.org\/wp-content\/uploads\/2022\/12\/Untitled-design-3.png\",\"contentUrl\":\"https:\/\/solvecfs.org\/wp-content\/uploads\/2022\/12\/Untitled-design-3.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/solvecfs.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Solve Shares Guidelines on Interactions with Biopharmaceutical Companies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/solvecfs.org\/#website\",\"url\":\"https:\/\/solvecfs.org\/\",\"name\":\"Solve ME\/CFS Initiative\",\"description\":\"Leveraging patient-centered research to cure ME\/CFS\",\"publisher\":{\"@id\":\"https:\/\/solvecfs.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/solvecfs.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/solvecfs.org\/#organization\",\"name\":\"The Solve ME\/CFS Initiative\",\"url\":\"https:\/\/solvecfs.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/solvecfs.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/solvecfs.org\/wp-content\/uploads\/2021\/08\/cropped-color.jpg\",\"contentUrl\":\"https:\/\/solvecfs.org\/wp-content\/uploads\/2021\/08\/cropped-color.jpg\",\"width\":362,\"height\":104,\"caption\":\"The Solve ME\/CFS Initiative\"},\"image\":{\"@id\":\"https:\/\/solvecfs.org\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/solvecfs.org\/#\/schema\/person\/c88bbebf36b00385b7b7cbc13be5c852\",\"name\":\"Karman Kregole\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/solvecfs.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5dd4c44c13e132382532383a67f36506?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5dd4c44c13e132382532383a67f36506?s=96&d=mm&r=g\",\"caption\":\"Karman Kregole\"},\"url\":\"https:\/\/solvecfs.org\/author\/kkregloesolvecfs-org\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Solve Shares Guidelines on Interactions with Biopharmaceutical Companies - Solve ME\/CFS Initiative","description":"Solve created a set of Guidelines on Interactions with Biopharmaceutical Companies to emphasize that all interactions between Solve M.E., industry, and the disease community should be transparent; should enable trust, accountability, and shared learning; and ultimately should work most efficiently and effectively toward advancing meaningful health outcomes for patients.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/","og_locale":"en_US","og_type":"article","og_title":"Solve Shares Guidelines on Interactions with Biopharmaceutical Companies - Solve ME\/CFS Initiative","og_description":"Solve created a set of Guidelines on Interactions with Biopharmaceutical Companies to emphasize that all interactions between Solve M.E., industry, and the disease community should be transparent; should enable trust, accountability, and shared learning; and ultimately should work most efficiently and effectively toward advancing meaningful health outcomes for patients.","og_url":"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/","og_site_name":"Solve ME\/CFS Initiative","article_published_time":"2023-10-02T20:15:11+00:00","article_modified_time":"2024-02-05T20:15:48+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/solvecfs.org\/wp-content\/uploads\/2022\/12\/Untitled-design-3.png","type":"image\/png"}],"author":"Karman Kregole","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Karman Kregole","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/#article","isPartOf":{"@id":"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/"},"author":{"name":"Karman Kregole","@id":"https:\/\/solvecfs.org\/#\/schema\/person\/c88bbebf36b00385b7b7cbc13be5c852"},"headline":"Solve Shares Guidelines on Interactions with Biopharmaceutical Companies","datePublished":"2023-10-02T20:15:11+00:00","dateModified":"2024-02-05T20:15:48+00:00","mainEntityOfPage":{"@id":"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/"},"wordCount":127,"publisher":{"@id":"https:\/\/solvecfs.org\/#organization"},"image":{"@id":"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/#primaryimage"},"thumbnailUrl":"https:\/\/solvecfs.org\/wp-content\/uploads\/2022\/12\/Untitled-design-3.png","articleSection":["Advocacy","Partners","Research"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/","url":"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/","name":"Solve Shares Guidelines on Interactions with Biopharmaceutical Companies - Solve ME\/CFS Initiative","isPartOf":{"@id":"https:\/\/solvecfs.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/#primaryimage"},"image":{"@id":"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/#primaryimage"},"thumbnailUrl":"https:\/\/solvecfs.org\/wp-content\/uploads\/2022\/12\/Untitled-design-3.png","datePublished":"2023-10-02T20:15:11+00:00","dateModified":"2024-02-05T20:15:48+00:00","description":"Solve created a set of Guidelines on Interactions with Biopharmaceutical Companies to emphasize that all interactions between Solve M.E., industry, and the disease community should be transparent; should enable trust, accountability, and shared learning; and ultimately should work most efficiently and effectively toward advancing meaningful health outcomes for patients.","breadcrumb":{"@id":"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/#primaryimage","url":"https:\/\/solvecfs.org\/wp-content\/uploads\/2022\/12\/Untitled-design-3.png","contentUrl":"https:\/\/solvecfs.org\/wp-content\/uploads\/2022\/12\/Untitled-design-3.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/solvecfs.org\/solve-shares-guidelines-on-interactions-with-biopharmaceutical-companies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/solvecfs.org\/"},{"@type":"ListItem","position":2,"name":"Solve Shares Guidelines on Interactions with Biopharmaceutical Companies"}]},{"@type":"WebSite","@id":"https:\/\/solvecfs.org\/#website","url":"https:\/\/solvecfs.org\/","name":"Solve ME\/CFS Initiative","description":"Leveraging patient-centered research to cure ME\/CFS","publisher":{"@id":"https:\/\/solvecfs.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/solvecfs.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/solvecfs.org\/#organization","name":"The Solve ME\/CFS Initiative","url":"https:\/\/solvecfs.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/solvecfs.org\/#\/schema\/logo\/image\/","url":"https:\/\/solvecfs.org\/wp-content\/uploads\/2021\/08\/cropped-color.jpg","contentUrl":"https:\/\/solvecfs.org\/wp-content\/uploads\/2021\/08\/cropped-color.jpg","width":362,"height":104,"caption":"The Solve ME\/CFS Initiative"},"image":{"@id":"https:\/\/solvecfs.org\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/solvecfs.org\/#\/schema\/person\/c88bbebf36b00385b7b7cbc13be5c852","name":"Karman Kregole","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/solvecfs.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5dd4c44c13e132382532383a67f36506?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5dd4c44c13e132382532383a67f36506?s=96&d=mm&r=g","caption":"Karman Kregole"},"url":"https:\/\/solvecfs.org\/author\/kkregloesolvecfs-org\/"}]}},"_links":{"self":[{"href":"https:\/\/solvecfs.org\/wp-json\/wp\/v2\/posts\/39793"}],"collection":[{"href":"https:\/\/solvecfs.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/solvecfs.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/solvecfs.org\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/solvecfs.org\/wp-json\/wp\/v2\/comments?post=39793"}],"version-history":[{"count":1,"href":"https:\/\/solvecfs.org\/wp-json\/wp\/v2\/posts\/39793\/revisions"}],"predecessor-version":[{"id":39794,"href":"https:\/\/solvecfs.org\/wp-json\/wp\/v2\/posts\/39793\/revisions\/39794"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/solvecfs.org\/wp-json\/wp\/v2\/media\/37402"}],"wp:attachment":[{"href":"https:\/\/solvecfs.org\/wp-json\/wp\/v2\/media?parent=39793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/solvecfs.org\/wp-json\/wp\/v2\/categories?post=39793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/solvecfs.org\/wp-json\/wp\/v2\/tags?post=39793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}